Exane Derivatives’s Cigna CI Stock Holding History

Exane Derivatives’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$75.6K	Buy	287 +161	+128%	+$41.5K	0.04%	285
2022 Q1	$30.2K	Buy	126 +124	+6,200%	+$29K	0.01%	627
2021 Q4	$459	Sell	2 -5,649	-100%	-$1.2M	﹤0.01%	776
2021 Q3	$1.13M	Sell	5,651 -6	-0.1%	-$1.3K	0.27%	76
2021 Q2	$1.33M	Buy	5,657 +11	+0.2%	+$2.75K	0.3%	72
2021 Q1	$1.36M	Sell	5,646 -176	-3%	-$39.2K	0.39%	57
2020 Q4	$1.21M	Buy	5,822 +5,626	+2,870%	+$1.1M	0.36%	58
2020 Q3	$33.2K	Sell	196 -478	-71%	-$84.1K	0.01%	399
2020 Q2	$126K	Sell	674 -27	-4%	-$5.12K	0.03%	261
2020 Q1	$124K	Buy	701 +456	+186%	+$88.5K	0.03%	256
2019 Q4	$51K	Sell	245 -1,680	-87%	-$308K	0.01%	357
2019 Q3	$292K	Sell	1,925 -1,300	-40%	-$212K	0.05%	200
2019 Q2	$508K	Buy	3,225 +1,938	+151%	+$304K	0.09%	171
2019 Q1	$207K	Buy	1,287 +870	+209%	+$159K	0.04%	217
2018 Q4	$79.2K	Sell	417 -16,663	-98%	-$3.48M	0.01%	339
2018 Q3	$3.56M	Buy	17,080 +3,735	+28%	+$692K	0.67%	35
2018 Q2	$2.27M	Buy	+13,345	New	+$2.31M	0.38%	60

Other funds holding CI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exane Derivatives's CI Position: Q2 2022 in Review

Exane Derivatives increased its Cigna (CI) stake by 128% in Q2 2022, buying an estimated $41.5K and bringing the position to 287 shares worth $75.6K. The position accounts for 0.04% of the portfolio, ranked #285.

Exane Derivatives first reported a position in CI in Q2 2018 and has held it in 17 quarters since. The position peaked at $3.56M in Q3 2018. 1,441 funds tracked by Wall St. Rank hold CI as of Q2 2022.

Exane Derivatives held 287 shares of Cigna worth $75.6K as of Q2 2022.
Exane Derivatives bought 161 Cigna shares in Q2 2022, an estimated $41.5K.
Cigna made up 0.04% of Exane Derivatives's portfolio in Q2 2022, its #285 holding.
Exane Derivatives first reported a position in Cigna in Q2 2018 and has held it in 17 quarters since.
Exane Derivatives's Cigna position peaked at $3.56M in Q3 2018.
1,441 funds tracked by Wall St. Rank held Cigna as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.